Superiority and equivalence in thrombolytic drugs: an interpretation

QJM. 2003 Feb;96(2):155-60. doi: 10.1093/qjmed/hcg020.
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Recombinant Proteins / therapeutic use
  • Streptokinase / therapeutic use
  • Tenecteplase
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • reteplase
  • Streptokinase
  • Tissue Plasminogen Activator
  • Tenecteplase